Published in N Engl J Med on September 07, 2006
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension (2009) 1.46
Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice. Am J Hypertens (2010) 0.94
Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol (2012) 0.93
Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study. PLoS One (2013) 0.86
Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension (2013) 0.80
Assessment of prevalence of preeclampsia from Dilla region of Ethiopia. BMC Res Notes (2015) 0.78
Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.76
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension (2007) 4.20
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA (2008) 3.16
Cadmium exposure and incident cardiovascular disease. Epidemiology (2013) 2.55
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 2.28
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study. J Clin Hypertens (Greenwich) (2011) 2.04
Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study. J Am Soc Nephrol (2006) 1.94
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol (2008) 1.91
High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol (2009) 1.79
Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol (2002) 1.70
Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study. Ann Intern Med (2013) 1.67
Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study. Environ Health Perspect (2009) 1.63
Urine arsenic and prevalent albuminuria: evidence from a population-based study. Am J Kidney Dis (2012) 1.59
Linkage analysis of glomerular filtration rate in American Indians. Kidney Int (2008) 1.59
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy (2003) 1.55
Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol (2003) 1.47
Arsenic species and selected metals in human urine: validation of HPLC/ICPMS and ICPMS procedures for a long-term population-based epidemiological study. Anal Methods (2012) 1.27
Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol (2012) 1.25
Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One (2010) 1.25
Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study. Cancer Epidemiol Biomarkers Prev (2013) 1.23
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation. Am J Obstet Gynecol (2012) 1.22
Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. Am J Kidney Dis (2008) 1.21
Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol (2002) 1.15
Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev (2010) 1.12
Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension (2013) 1.11
Gestational diabetes: implications for cardiovascular health. Curr Diab Rep (2012) 1.11
Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia. Hypertension (2007) 1.09
Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos (2010) 1.09
Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol (2010) 1.07
Approaches to preparing young scholars for careers in interdisciplinary team science. J Investig Med (2014) 1.04
Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study. Am J Epidemiol (2013) 1.03
Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. Nutr Metab Cardiovasc Dis (2009) 1.02
PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. J Clin Lipidol (2009) 1.02
Cadmium exposure and cancer mortality in a prospective cohort: the strong heart study. Environ Health Perspect (2014) 0.96
The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum Genet (2010) 0.96
Association of global DNA methylation and global DNA hydroxymethylation with metals and other exposures in human blood DNA samples. Environ Health Perspect (2014) 0.96
The impact of pre-pregnancy body mass index on the risk of gestational diabetes. J Matern Fetal Neonatal Med (2011) 0.96
Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis (2007) 0.96
Pregnancy and infection. N Engl J Med (2014) 0.96
Sterile pyuria. N Engl J Med (2015) 0.95
Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles. Kidney Int (2003) 0.95
Linkage study of fibrinogen levels: the Strong Heart Family Study. BMC Med Genet (2008) 0.94
Advances in the understanding of eclampsia. Curr Hypertens Rep (2008) 0.94
Cadmium exposure and incident peripheral arterial disease. Circ Cardiovasc Qual Outcomes (2013) 0.94
Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study. Am J Kidney Dis (2012) 0.92
Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine. Environ Health Perspect (2013) 0.92
Preeclampsia pathogenesis: "triple a rating"-autoantibodies and antiangiogenic factors. Hypertension (2008) 0.92
Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease. Am J Cardiol (2011) 0.91
Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study. J Nephrol (2009) 0.91
Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation (2013) 0.91
Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol (2009) 0.91
Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study. Diabetes Care (2012) 0.91
Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis. Thyroid (2005) 0.90
Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study. Stroke (2008) 0.90
The renal response to preeclampsia. Semin Nephrol (2004) 0.90
Variants in CPT1A, FADS1, and FADS2 are Associated with Higher Levels of Estimated Plasma and Erythrocyte Delta-5 Desaturases in Alaskan Eskimos. Front Genet (2012) 0.89
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial. J Clin Hypertens (Greenwich) (2009) 0.89
Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos. Am J Clin Nutr (2010) 0.89
Preeclampsia and the kidney: footprints in the urine. Am J Obstet Gynecol (2007) 0.89
Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol (2013) 0.89
The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study. Epidemiology (2015) 0.89
Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study. Environ Health (2013) 0.88
Linkage analysis of albuminuria. J Am Soc Nephrol (2009) 0.88
A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. Am J Kidney Dis (2008) 0.87
The association of genetic variants of type 2 diabetes with kidney function. Kidney Int (2012) 0.87
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Am J Perinatol (2012) 0.87
Angiotensin II infusion alters vascular function in mouse resistance vessels: roles of O and endothelium. J Vasc Res (2005) 0.86
Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study. Am J Hum Biol (2010) 0.86
Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit (2012) 0.86
Differences in risk factors for coronary heart disease among diabetic and nondiabetic individuals from a population with high rates of diabetes: the Strong Heart Study. J Clin Endocrinol Metab (2012) 0.85
Genetic influence on variation in serum uric acid in American Indians: the strong heart family study. Hum Genet (2009) 0.85
Perspectives on the proposed gestational diabetes mellitus diagnostic criteria. Obstet Gynecol (2013) 0.84
Utilizing harmonization and common surveillance methods to consolidate 4 cohorts: the Western Alaska Tribal Collaborative for Health (WATCH) study. Int J Circumpolar Health (2013) 0.84
Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure. Arch Toxicol (2013) 0.84
Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol (2003) 0.84
Social- and behavioral-specific genetic effects on blood pressure traits: the Strong Heart Family Study. Circ Cardiovasc Genet (2009) 0.84
Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. Stroke (2011) 0.83
The proposed GDM diagnostic criteria: a difference, to be a difference, must make a difference. J Matern Fetal Neonatal Med (2012) 0.83
First-trimester prediction of early preeclampsia: a possibility at last! Hypertension (2009) 0.83
Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy. Ther Drug Monit (2012) 0.83
All-cause, cardiovascular, and cancer mortality in western Alaska Native people: western Alaska Tribal Collaborative for Health (WATCH). Am J Public Health (2014) 0.83
Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study. Diabetes Care (2011) 0.82
Reduced hippocampal brain-derived neurotrophic factor (BDNF) in neonatal rats after prenatal exposure to propylthiouracil (PTU). Endocrinology (2012) 0.82
Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study). Am J Cardiol (2009) 0.82
Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study. Am J Clin Nutr (2012) 0.82
Generalization of associations of kidney-related genetic loci to American Indians. Clin J Am Soc Nephrol (2013) 0.82
Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects. Physiol Genomics (2011) 0.81
A QTL for genotype by sex interaction for anthropometric measurements in Alaskan Eskimos (GOCADAN Study) on chromosome 19q12-13. Obesity (Silver Spring) (2011) 0.81
Meta-analysis of genome-wide linkage scans for renal function traits. Nephrol Dial Transplant (2011) 0.81
Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. J Clin Hypertens (Greenwich) (2012) 0.81
Pregnancy and chronic kidney disease. Semin Nephrol (2011) 0.81
Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies. J Clin Hypertens (Greenwich) (2011) 0.80
Sex-specific associations of nutrition with hypertension and systolic blood pressure in Alaska Natives findings from the GOCADAN study. Int J Circumpolar Health (2011) 0.80
Albuminuria among Alaska Natives--findings from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Nephron Clin Pract (2010) 0.80
Angiogenic dysfunction in molar pregnancy. Am J Obstet Gynecol (2010) 0.80
Unraveling the mysteries of preeclampsia. Am J Obstet Gynecol (2005) 0.80
Aldosterone, maternal volume status and healthy pregnancies: a cycle of differing views. Nephrol Dial Transplant (2009) 0.80
Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience. J Diabetes Complications (2011) 0.80
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study. Genet Epidemiol (2013) 0.80
The arterial system in pre-eclampsia and chronic hypertension with superimposed pre-eclampsia. BJOG (2005) 0.79
Increased protein-coding mutations in the mitochondrial genome of African American women with preeclampsia. Reprod Sci (2012) 0.79